Oblak, Adrijana
Hribar, Maša
Hristov, Hristo
Gregorič, Matej
Blaznik, Urška
Osredkar, Joško
Kušar, Anita
Žmitek, Katja
Lavriša, Živa
Zaletel, Tjaša
Krhin, Blaž
Pravst, Igor http://orcid.org/0000-0001-8634-1778
Gaberšček, Simona
Zaletel, Katja http://orcid.org/0009-0004-8823-3489
Funding for this research was provided by:
The Slovenian Research and Innovation Agency (L3-8213, L3-8213, L3-8213, L3-8213, L3-8213, L3-8213, L3-8213, L3-8213, L3-8213, L3-8213, L3-8213, L3-8213)
EC | Horizon 2020 Framework Programme (634453, 634435, 634453, 634453, 634453, 634453, 634453, 634453, 634453, 634453, 634453, 634453)
Article History
Received: 24 October 2023
Revised: 30 July 2024
Accepted: 1 August 2024
First Online: 8 August 2024
Competing interests
: The authors declare no competing interests.
: The Nutrihealth and EUthyroid studies were approved by the Slovenian National Medical Ethics Committee (Ministry of Health, Republic of Slovenia). Nutrihealth study had identification number 0120-337/2016-4 and was registered at ClinicalTrials.gov (ID: NCT03284840). EUthyroid study had identification number 0120-508/2017-2.